Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-07-11

FDA Approved: ADAPALENE — Supplemental Application (CALL INC. (dba Rochester Pharmaceuticals))

View source ↗

Summary

FDA approved a supplemental application for adapalene, signaling changes to the existing approval (e.g., labeling or formulation).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)

Snippet

SUPPL AP for ADAPALENE (ADAPALENE)